Breast Implant Cancer Panic: Wakefieldism Rises Again

  • by: |
  • 01/27/2011
Here is what the FDA concluded about a possible association between breast implants and a rare form of non-Hodgkins lymphoma called anaplastic large cell lymphoma (ALCL). Read more here.
 
It is not possible to confirm with statistical certainty that breast implants cause ALCL. At this time, data appear to indicate that the incidence of ALCL is very low, even in breast implant patients. Currently it is not possible to identify a type of implant (silicone versus saline) or a reason for implant (reconstruction versus aesthetic augmentation) associated with a smaller or greater risk.

The FDA also noted 3 in 100 million women per year in the United States are diagnosed with ALCL in the breast.  As in 0.000003% of women. 
 
There were 60 reported cases of ALCL in women with breast implants worldwide from 1997-2010.   The average time women between getting implants and a ALCL diagnosis was 8 years.   
 
Should women with implants be concerned?  The FDA suggests follow up for any persistent swelling or fluid build up.  And    cautions that over-reaction could lead to even worse problems for women:
 
“..if we biopsy every abnor­mality – such as a minor thick­ening or fluid accu­mu­lation adjacent to a breast implant – we’ll hike up the costs and, more impor­tantly, the com­pli­ca­tions asso­ciated: With every needle stick there’s a risk of infection, addi­tional scar for­mation and more. On the other hand, you wouldn’t want to overlook a treatable, early-stage lym­phoma. Women need to know of the risks of implants, which can only be deter­mined if doctors thor­oughly inves­tigate these sorts of complications.”
 
And the risk of dying?  Early diagnosis and treatment for all forms ALCL is essentially a cure.  And relative to the risks of dying from heart disease and diabetes the risks seem fairly insignificant. 
 
But if you read most of the media outlets and websites in the last couple of days you would have thought that implants were “linked” conclusively to an increased risk of cancer for every woman who has them:
 
Chicago Sun-Times - Monifa Thomas -
Boston Globe - Deborah Kotz -
Wall Street Journal - Jennifer Corbett Dooren, Alicia Mundy -
ABC News - Lara Salahi 
Bloomberg - Catherine Larkin

AP’s Matt Perrone did a great job reporting the real risk-benefit bottom line but the Huffington Post managed to turn his account inside out with this headline:
 

Blogs were not much better for the most part:
 
New York Times (blog) - Toby Bilanow 
CNN (blog)
 
WebMD FDA announced that there is a link between breast implants and a very rare form of blood cancer. Read more here 

Actually WebMD the FDA used the term “a possible association”
 
The rare exceptions:

FDA Reports on Association of Breast Implants and a Rare Form of Lymphoma
By Elaine Schattner, M.D., on January 27th, 2011
and

5 hours ago by Katherine Hobson
 
Even assuming 60 cases among 5 million women, that's about one case per 83333 women. http://blogs.wsj.com/health/
 
(Actually it is 60 cases among 5 million over 10 years but we should get the point)
Last week the media was congratulating itself for reporting that Andrew Wakefield was a fraud after giving him an evidence free pass for over a decade.  But as Gary Schweitzer warned:
 
“Unfortunately, journalism played a key role in promoting Wakefield's claims. The "Respectful Insolence" blog referred to one journalist as CBS' resident anti-vaccine propagandist. Around the world there were many other examples of journalists' unquestioning acceptance of the vaccine scares.
 
The BMJ reminds us that "the damage to public health continues, fuelled by unbalanced media reporting and an ineffective response from government, researchers, journals, and the medical profession."
 

Didn’t take long for mainstream outlets to go back to their unhealthy habits…
 

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog